Isodiol International Inc ISOLF

ISOL is the World's Premiere CBD Company

[LordoftheMarket]

ISOL ISODIOL INTERNATIONAL INC

Isodiol International Inc. (CSE: ISOL / OTCQB: ISOLF) (Frankfurt: LB6A) – Initiating; Leading Cannabis/CBD Company Expanding Rapidly

https://www.researchpool.com/provider/fundamental-research/isodiol-international-inc-isol-isodiol-international-inc-cse-isol-otcqb-isolf-frankfurt-lb6a-initia
 

Fifteen companies currently qualify for inclusion, with six filing in U.S dollars and nine in the Canadian currency.  Two Canadian-listed companies reported financials late last week, including Isodiol International (CSE: ISOL) (OTC: ISOLF) and MPX Bioceutical (CSE: MPX) (OTC: MPXEF), which have been  updated to reflect the results:

Isodiol International reported sales of C$5.89 million in its FY18-Q3 ending 12/31, which represented a 16% gain from Q2. The company generated an operating profit of C$202,254 during the quarter but used C$7.5 million to fund operations. MPX Bioecutical sales of C$4.48 million in its FY18-Q3 ending 12/31, which represent the revenue from its Arizona operations, grew 2% from the prior quarter. The company reported an operating loss of $2.7 million, with adjusted EBITDA of $-1.18 million. In its conference call hosted on 3/8, the company provided guidance for sales of C$6 million in Q4, which also includes revenue from Nevada, and suggested that its Arizona operations will generate sales of more than C$40 million in Fiscal 2019.